Related Experiment Videos
The search for atrial fibrillation and its impact on public health
Anna Lam1, Eleni Goulouti1, Laurent Roten1
1Department of Cardiology, Inselspital, Bern University Hospital and University of Bern, Switzerland.
Insights
Atrial fibrillation (AF) can be symptomatic or silent, but both forms carry a risk of thromboembolism. Early detection and treatment, especially oral anticoagulation, are crucial for preventing strokes and improving public health outcomes.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Atrial fibrillation (AF) presents with varying symptoms, impacting treatment and detection.
- Silent or subclinical AF poses a significant, often unrecognized, thromboembolic risk.
- Effective prevention of thromboembolism is critical for managing AF patients.
Purpose of the Study:
- To review current screening recommendations for atrial fibrillation.
- To evaluate the impact of silent atrial fibrillation across different clinical contexts.
- To highlight the public health significance of early AF detection and treatment.
Main Methods:
- Literature review of screening guidelines for atrial fibrillation.
- Analysis of studies investigating the thromboembolic risk associated with silent AF.
- Examination of the clinical impact of early detection and oral anticoagulation therapy.
Main Results:
- Atrial fibrillation, whether symptomatic or silent, is linked to thromboembolic events.
- Early identification of AF in high-risk individuals can mitigate stroke risk.
- Screening strategies and timely anticoagulation are key public health interventions.
Conclusions:
- Screening for atrial fibrillation is essential, particularly in at-risk populations.
- Addressing silent AF through early detection and treatment significantly reduces thromboembolic complications.
- Proactive management of AF has substantial public health implications.
Abstract:
Atrial fibrillation may be clearly symptomatic and is easily amenable to state-of-the-art treatment, most importantly oral anticoagulation therapy for the prevention of thromboembolism. However, atrial fibrillation may also go unnoticed for long periods in many patients. This silent or subclinical atrial fibrillation is nevertheless associated with thromboembolic risk just like clinically evident atrial fibrillation. Early detection of atrial fibrillation in patients at increased thromboembolic risk and consequent oral anticoagulation therapy may have a significant impact on public health. This review focuses on screening recommendations for atrial fibrillation and on the impact of silent atrial fibrillation in various clinical scenarios.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Rheumatic Heart Disease I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias